These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25278732)

  • 41. Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis.
    Tran LT; Peacock A; Colledge S; Memedovic S; Grebely J; Leung J; Larney S; Trickey A; Stone J; Vickerman P; Hickman M; Degenhardt L
    Int J Drug Policy; 2020 Oct; 84():102866. PubMed ID: 32712484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
    Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
    Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.
    Thakarar K; Nenninger K; Agmas W
    Infect Dis Clin North Am; 2020 Sep; 34(3):605-620. PubMed ID: 32782104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.
    Mukherjee TI; Pillai V; Ali SH; Altice FL; Kamarulzaman A; Wickersham JA
    Int J Drug Policy; 2017 Sep; 47():144-152. PubMed ID: 28652072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Harm reduction history, response, and current trends in Asia.
    Thomson N
    J Food Drug Anal; 2013 Dec; 21(4):S113-S116. PubMed ID: 25264414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
    Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
    Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV prevalence among people who inject drugs (PWID) and related factors in Iran: a systematic review, meta-analysis and trend analysis.
    Rahimi J; Gholami J; Amin-Esmaeili M; Fotouhi A; Rafiemanesh H; Shadloo B; Rahimi-Movaghar A
    Addiction; 2020 Apr; 115(4):605-622. PubMed ID: 31631425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Moving from a project to programmatic response: scaling up harm reduction in Asia.
    Chatterjee A; Sharma M
    Int J Drug Policy; 2010 Mar; 21(2):134-6. PubMed ID: 20079618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.
    Goodin A; Fallin-Bennett A; Green T; Freeman PR
    Harm Reduct J; 2018 Jan; 15(1):4. PubMed ID: 29370808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Injection and sexual risk among people who use or inject drugs in Kampala, Uganda: An exploratory qualitative study.
    Dickson-Gomez J; Twaibu W; Christenson E; Dan K; Anguzu R; Homedi E; Mbona Tumwesigye N
    PLoS One; 2020; 15(4):e0231969. PubMed ID: 32320448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The risk environments of people who use drugs accessing two harm reduction centers in Tehran, Iran: A qualitative study.
    Bastani P; Marshall BDL; Rahimi-Movaghar A; Noroozi A
    Int J Drug Policy; 2019 Jan; 63():90-96. PubMed ID: 30513474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Options for reducing HIV transmission related to the dead space in needles and syringes.
    Zule WA; Pande PG; Otiashvili D; Bobashev GV; Friedman SR; Gyarmathy VA; Des Jarlais DC
    Harm Reduct J; 2018 Jan; 15(1):3. PubMed ID: 29334973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
    Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
    Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
    Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
    Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: A concurrent mixed-method feasibility study.
    Biello K; Salhaney P; Valente PK; Childs E; Olson J; Earlywine JJ; Marshall BD; R Bazzi A
    Drug Alcohol Depend; 2020 Sep; 214():108167. PubMed ID: 32679521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies confirm effectiveness of harm reduction for people who inject drugs.
    Arkin E
    HIV AIDS Policy Law Rev; 2011 Oct; 15(3):29. PubMed ID: 22165261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of harm reduction service utilization and HIV incidence among people who inject drugs in Ukraine: A two-part latent profile analysis.
    Ompad DC; Wang J; Dumchev K; Barska J; Samko M; Zeziulin O; Saliuk T; Varetska O; DeHovitz J
    Int J Drug Policy; 2017 May; 43():7-15. PubMed ID: 28160736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan.
    Stringer KL; Mukherjee T; McCrimmon T; Terlikbayeva A; Primbetovac S; Darisheva M; Hunt T; Gilbert L; El-Bassel N
    Int J Drug Policy; 2019 Jun; 68():27-36. PubMed ID: 30981165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO).
    Mesquita F; Jacka D; Ricard D; Shaw G; Tieru H; Hu Y; Poundstone K; Salva M; Fujita M; Singh N
    Harm Reduct J; 2008 Aug; 5():26. PubMed ID: 18680604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.